SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)

NCT06401005 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
51
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hubei Cancer Hospital